147 related articles for article (PubMed ID: 15725865)
41. Chapter 13: Primary screening of cervical cancer with human papillomavirus tests.
Franco EL
J Natl Cancer Inst Monogr; 2003; (31):89-96. PubMed ID: 12807951
[TBL] [Abstract][Full Text] [Related]
42. Screening for cervical cancer.
Wright TC; Goldie SJ; Cain JM; Howett MK
Science; 2000 Dec; 290(5497):1651. PubMed ID: 11186376
[No Abstract] [Full Text] [Related]
43. Low prevalence of high-risk HPV in older women not attending organized cytological screening: a pilot study.
Wikström I; Stenvall H; Wilander E
Acta Derm Venereol; 2007; 87(6):554-5. PubMed ID: 17989903
[No Abstract] [Full Text] [Related]
44. The development of a quality assurance programme for HPV testing within the UK NHS cervical screening LBC/HPV studies.
Cubie HA; Moore C; Waller M; Moss S;
J Clin Virol; 2005 Aug; 33(4):287-92. PubMed ID: 16036178
[TBL] [Abstract][Full Text] [Related]
45. High-risk human papillomavirus detection in self-sampling compared to physician-taken smear in a responder population of the Dutch cervical screening: Results of the VERA study.
Ketelaars PJW; Bosgraaf RP; Siebers AG; Massuger LFAG; van der Linden JC; Wauters CAP; Rahamat-Langendoen JC; van den Brule AJC; IntHout J; Melchers WJG; Bekkers RLM
Prev Med; 2017 Aug; 101():96-101. PubMed ID: 28579497
[TBL] [Abstract][Full Text] [Related]
46. HPV testing in liquid specimens.
Geyer SJ
Acta Cytol; 2006; 50(5):599-600. PubMed ID: 17017457
[No Abstract] [Full Text] [Related]
47. To eliminate cervical cancer in Canada, nationwide funding of self-sampling for human papillomavirus is needed.
Charlebois S; Kean S
CMAJ; 2024 Jun; 196(21):E729-E730. PubMed ID: 38830678
[No Abstract] [Full Text] [Related]
48. Overview of the cytology laboratory: specimen processing through diagnosis.
Joste N
Obstet Gynecol Clin North Am; 2008 Dec; 35(4):549-63; viii. PubMed ID: 19061816
[TBL] [Abstract][Full Text] [Related]
49. Preference of specimen collection methods for human papillomavirus detection for cervical cancer screening: a cross-sectional study of high-risk women in Mombasa, Kenya.
Manguro GO; Masese LN; Mandaliya K; Graham SM; McClelland RS; Smith JS
Reprod Health; 2018 Dec; 15(1):206. PubMed ID: 30541595
[TBL] [Abstract][Full Text] [Related]
50. Acceptability of human papillomavirus self-sampling for cervical-cancer screening in under-screened Māori and Pasifika women: a pilot study.
Brewer N; Foliaki S; Bromhead C; Viliamu-Amusia I; Pelefoti-Gibson L; Jones T; Pearce N; Potter JD; Douwes J
N Z Med J; 2019 Jun; 132(1497):21-31. PubMed ID: 31220062
[TBL] [Abstract][Full Text] [Related]
51. [Testing for human papillomavirus in cervical cancer screening].
Kjaer SK
Ugeskr Laeger; 2002 Jan; 164(2):173-5. PubMed ID: 11831083
[No Abstract] [Full Text] [Related]
52. The HPV test in cervical screening: a brave new world?
Desai MS; Cubie HA
Cytopathology; 2005 Feb; 16(1):3-6. PubMed ID: 15859308
[No Abstract] [Full Text] [Related]
53. Human papillomavirus DNA testing for cervical cancer screening: practical aspects in developing countries.
Belinson SE; Belinson JL
Mol Diagn Ther; 2010 Aug; 14(4):215-22. PubMed ID: 20799763
[TBL] [Abstract][Full Text] [Related]
54. Reasons for rejection of self-collected samples for cervical screening.
Brotherton JM; Hawkes D; Saville M
Med J Aust; 2022 Mar; 216(4):214. PubMed ID: 35148569
[No Abstract] [Full Text] [Related]
55. ACS updates guideline for the early detection of cervical neoplasia and cancer. American Cancer Society.
Schroeder BM;
Am Fam Physician; 2003 May; 67(9):2011, 2015-6. PubMed ID: 12751666
[No Abstract] [Full Text] [Related]
56. Low-income, Asian American women benefit from human papillomavirus self-sampling tests.
Printz C
Cancer; 2020 Feb; 126(3):469. PubMed ID: 31944282
[No Abstract] [Full Text] [Related]
57. The role of human papillomavirus testing in cervical cancer screening.
Morasse L; Davidov A; Castellanos MR
JAAPA; 2009 Nov; 22(11):20-3. PubMed ID: 19999172
[No Abstract] [Full Text] [Related]
58. HPV swab self-collection and cervical cancer in women who have sex with women.
McGauran MF; Pendlebury A
Med J Aust; 2020 Feb; 212(3):106-107.e1. PubMed ID: 31872876
[No Abstract] [Full Text] [Related]
59. Results of Self-Sampling Methodology Impression for Cervical Cancer Screening in Mongolia.
Tsedenbal B; Enebish G; Tserensodnom B; Saio M
Asian Pac J Cancer Prev; 2022 Dec; 23(12):4099-4107. PubMed ID: 36579991
[TBL] [Abstract][Full Text] [Related]
60. [HPV self-sampling for cervical cancer screening in Denmark].
Tranberg M; Andersen B
Ugeskr Laeger; 2018 Nov; 180(48):. PubMed ID: 30518468
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
